ExPrimary develops and commercializes high-performance and very low-cost analytical instruments primarily targeting needs for bioanalysis. The core revenue model is consumable flow through an expanded install-base of instruments. We have prototyped 13 instruments in 9 instrument families and are addressing the diagnostic needs of personalized medicine including therapeutic drug monitoring for advanced immunomodulatory and cell-based therapies.